Surgeon Liable for Full $1.6M Medical Malpractice Verdict (2025)

Surgeon Liable for Full $1.6M Medical Malpractice Verdict (2025)

October 24, 2025 | Newark, NJ — MedLegalNews.com — A New Jersey appellate court has upheld a lower court ruling that places full financial liability on a surgeon for a $1.6 million medical malpractice verdict, rejecting arguments that co-defendants should share the damages. The decision reinforces the state’s strict interpretation of comparative negligence in surgical […]

Surgeon Liable for Full $1.6M Medical Malpractice Verdict (2025) Read Post »

California AI Safety and Healthcare Investor Laws Tighten Oversight (2025)

California AI Safety and Healthcare Investor Laws Tighten Oversight (2025)

October 22, 2025 | Sacramento, CA — MedLegalNews.com — California has enacted a pair of legislative measures—SB 53 on AI Safety and AB 1415 on healthcare investor transparency—marking a significant shift in how the state governs technology and financial influence in the medical sector. Together, the laws reflect California’s growing emphasis on AI Safety, accountability,

California AI Safety and Healthcare Investor Laws Tighten Oversight (2025) Read Post »

High Court Declines FDA Stem Cell Regulation Fight

High Court Declines FDA Stem Cell Regulation Fight

October 20, 2025 | Washington, D.C. — MedLegalNews.com — The U.S. Supreme Court has declined to review a challenge to the Food and Drug Administration’s (FDA) authority over stem cell therapies, effectively upholding lower court rulings that classify certain regenerative treatments as drugs subject to federal oversight. The decision preserves the FDA’s power to regulate

High Court Declines FDA Stem Cell Regulation Fight Read Post »

Gilead COVID Patent Infringement Dispute with Chinese Research Org (2025)

Gilead COVID Patent Infringement Dispute with Chinese Research Org (2025)

October 17, 2025 | Beijing, China — MedLegalNews.com — A leading Chinese research organization has accused Gilead Sciences Inc. of infringing on a COVID-19 treatment patent, igniting a high-stakes international dispute over intellectual property and pharmaceutical innovation. The allegations center on compounds related to antiviral formulations used during the global pandemic response. Chinese Institute Claims

Gilead COVID Patent Infringement Dispute with Chinese Research Org (2025) Read Post »

Florida Opioid Law Weakened DEA Oversight, Jury Told (2025)

Florida Opioid Law Weakened DEA Oversight, Jury Told (2025)

October 13, 2025 | Miami, FL — MedLegalNews.com — A Florida federal jury has been told that a 2016 opioid law, which eased restrictions on opioid distribution monitoring, may have undermined the U.S. Drug Enforcement Administration’s (DEA) ability to curb prescription drug abuse. The revelation came amid a high-profile civil case scrutinizing how pharmaceutical distributors

Florida Opioid Law Weakened DEA Oversight, Jury Told (2025) Read Post »

Courts Upholding Gender-Affirming Care Bans After Skrmetti

Courts Upholding Gender-Affirming Care Bans After Skrmetti

October 10, 2025 | Washington, D.C. — MedLegalNews.com — In the wake of the landmark U.S. v. Skrmetti decision, federal appeals courts in Arkansas and Oklahoma have reaffirmed state bans on gender-affirming medical care for transgender minors, marking a pivotal shift in post-Skrmetti legal precedent. The rulings signal that appellate courts are increasingly willing to

Courts Upholding Gender-Affirming Care Bans After Skrmetti Read Post »

California Bill AB 1415: Oversight of Private-Equity Ownership in Healthcare

Oct 8, 2025 | Sacramento, CA — MedLegalNews.com — California is preparing to pull back the curtain on who really owns its hospitals and medical networks. Assembly Bill 1415, known as California AB 1415, would require financial investors—including private-equity firms, hedge funds, and management service companies—to notify state regulators before completing any acquisition or control

California Bill AB 1415: Oversight of Private-Equity Ownership in Healthcare Read Post »

Insurer Escapes Duty to Cover Lab in COVID-19 Tests Suit

Insurer Escapes Duty to Cover Lab in COVID-19 Tests Suit

October 6, 2025 | Philadelphia, PA — MedLegalNews.com — A federal court in the Eastern District of Pennsylvania has held that Pennsylvania insurer coverage does not extend to a laboratory being sued by a COVID-19 test manufacturer. The ruling marks a significant development in how courts interpret coverage exclusions tied to medical testing and professional

Insurer Escapes Duty to Cover Lab in COVID-19 Tests Suit Read Post »

Atty’s ‘Highly Prejudicial Falsehood’ Triggers Retrial in Pennsylvania Medical Malpractice Case

Atty’s ‘Highly Prejudicial Falsehood’ Triggers Retrial in Pennsylvania Medical Malpractice Case

October 3, 2025 | Philadelphia, PA — MedLegalNews.com — A Pennsylvania Superior Court panel has vacated a jury’s $869,000 award in a medical malpractice lawsuit arising from a foot amputation, ruling that the plaintiff’s attorney made a materially false statement during opening arguments. The appellate judges concluded that the misrepresentation—asserting that no vascular surgeon in

Atty’s ‘Highly Prejudicial Falsehood’ Triggers Retrial in Pennsylvania Medical Malpractice Case Read Post »

Scroll to Top